709040-80-2

Upstream product

• 100-39-0 benzyl bromide 
• 709040-78-8 11-azidoundecyl 3,4-O-isopropylidene-β-D-galactopyranoside 
• 709040-77-7 11-azidoundecyl β-D-galactopyranoside 
• 122161-09-5 11-azidoundecanol 
• 1611-56-9 1-Bromo-11-hydroxyundecane 
• 2592-58-7 1,2,3,4,6-Penta-O-benzoyl-α-D-galactopyranose 

Downstream Products

• 709041-02-1 11-azidoundecyl O-(methyl 5-N,N-diacetylamino-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonate)-(2->3)-2,6-di-O-benzyl-β-D-galactopyranoside 
• 709040-99-3 11-azido-undecyl O-[5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid]-(2->8)-O-(5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranosylonic acid)-2,6-di-O-benzyl-β-D-galactopyranoside 
• 709040-98-2 C₆₆H₉₁N₅O₂₇ 
• 709040-82-4 11-azidoundecyl 2,6-di-O-benzyl-β-D-galactopyranoside 

Relevant academic research and scientific papers

Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barre syndrome

Guillain-Barre syndrome is a postinfectious, autoimmune neuropathy resulting in neuromuscular paralysis. Auto-antibodies, often induced by bacterial infection, bind to human gangliosides possessing monosialoside and diasialoside epitopes and impair the fu